Thermo Fisher Scientific stock rises on reshoring contract talk, Nvidia lab deal and exec shuffle
Thermo Fisher Scientific shares rose 1.4% to $615.46 after CEO Marc Casper announced new U.S. onshoring contracts at the J.P. Morgan Healthcare Conference. The company also unveiled a lab automation partnership with Nvidia and confirmed upcoming executive changes. Investors await Thermo’s January 29 results and 2026 outlook.